BLOG

Biotech Stock Hits Fresh High As It Plans To Launch A Drug Amid Virus

Immunomedics (IMMU) isn’t concerned the coronavirus pandemic could slow its launch of a new breast cancer treatment, an executive said Thursday, as IMMU stock rocketed on the approval.